Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.4515
-0.0033 (-0.73%)
At close: Apr 23, 2025, 4:00 PM
0.4426
-0.0089 (-1.97%)
Pre-market: Apr 24, 2025, 6:26 AM EDT
Tenaya Therapeutics Employees
Tenaya Therapeutics had 97 employees as of December 31, 2024. The number of employees decreased by 43 or -30.71% compared to the previous year.
Employees
97
Change (1Y)
-43
Growth (1Y)
-30.71%
Revenue / Employee
n/a
Profits / Employee
-$1,145,660
Market Cap
72.94M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 97 | -43 | -30.71% |
Dec 31, 2023 | 140 | -1 | -0.71% |
Dec 31, 2022 | 141 | 35 | 33.02% |
Dec 31, 2021 | 106 | 31 | 41.33% |
Dec 31, 2020 | 75 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
TNYA News
- 23 days ago - Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting - GlobeNewsWire
- 4 weeks ago - Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models - GlobeNewsWire
- 5 weeks ago - Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology's Annual Scientific Session - GlobeNewsWire
- 6 weeks ago - Tenaya Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - Tenaya Therapeutics Announces Pricing of Public Offering - GlobeNewsWire
- 7 weeks ago - Tenaya Therapeutics Announces Proposed Public Offering - GlobeNewsWire
- 7 weeks ago - Tenaya Therapeutics to Participate in Upcoming March Investor Conferences - GlobeNewsWire
- 2 months ago - Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine - GlobeNewsWire